MRI in Diagnosing Solid Tumors of the Eye and Orbit

NAActive, not recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 18, 2006

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Eye Cancer
Interventions
PROCEDURE

dynamic contrast-enhanced MRI

Studies will be performed on standard clinical MR Systems which are available on Campus. With the proposed imaging technique, we are able to acquire a 3D volume covering the orbit with a temporal resolution of approximately 15s. The affected eye will be immobilized to reduce motion artifacts. A routinely used MR contrast agent will be administered in a dose of 0.1mmol/kg bodyweight.

Trial Locations (1)

43210

Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

University of Cincinnati

OTHER